The Celonic Group, a Swiss-based Quality Biologics Contract Development and Manufacturing Organization (CDMO) has opened a new Biologics Development Center and Pilot Plant in Basel, Switzerland.   This laboratory expansion will help pharmaceutical companies develop and optimize processes using bioprocessing technologies such as Process Intensification and Perfusion. These technologies cut the cost and risks of scaling up the production of biologic medicines, making them more affordable and acc...